Role of reactive oxygen species in glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 15, Issue 8, 2000, Pages 1127-1132

  Gwinner, Wilfried ^a   Gröne, Hermann Josef ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

GLOMERULONEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0342626743     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.8.1127     Document Type: Short Survey

References (77)

1. Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991; 3: 1-7
2. Halliwell B. Oxidants and human disease. some new concepts. FASEB J 1987; 1: 358-364
3. Bast A, Haenen GRMM, Doelman CJA. Oxidants and antioxidants. state of the art. Am J Med 1991; 91 [Suppl. 3C]: 2S-13S
4. McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 1993; 26: 351-357
5. Angermuller S, Bruder G, Volkl A, Wesch H, Fahimi HD. Localization of xanthine oxidase in crystalline cores of peroxisomes. A cytochemical and biochemical study. Eur J Cell Biol 1987; 45: 137-144
6. Asayama K, Yokota S, Dobashi K, Hayashibe H, Kawaoi A, Nakazawa S. Purification and immunoelectron microscopic localization of cellular glutathione peroxidase in rat hepatocytes: quantitative analysis by postembedding method. Histochemistry 1994; 102: 213-219
7. Calabrese EJ, Canada AT. Catalase. Its role in xenobiotic detoxification. Pharmacol Ther 1989; 44: 297-307
8. Critchley DJ, Rance DJ, Beedham C. Subcellular localisation of guinea pig hepatic molybdenum hydroxylases. Biochem Biophys Res Commun 1992; 185: 54-59
9. Cross AR, Jones OTG. Enzymic mechanisms of superoxide production. Biochim Biophys Acta 1991; 1057: 281-298
10. Geller BL, Winge DR. Rat liver Cu,Zn-superoxide dismutase. Subcellular location in lysosomes. J Biol Chem 1982; 257: 8945-8952
11. Johansson A, Jesaitis AJ, Lundqvist H et al. Different subcellular localization of cylochrome b and the dormant NADPH-oxidase in neutrophils and macrophages: effect on the production of reactive oxygen species during phagocytosis. Cell Immunol 1995; 161: 61-71
12. Kisker C, Schindelin H, Rees DC. Molybdenum-cofactor-containing enzymes, structure and mechanism. Annu Rev Biochem 1997; 66: 233-267
13. Morre DJ, Brightman AO. NADH oxidase of plasma membranes. J Bioenerg Biomembr 1991; 23: 469-489
14. Muse KE, Oberley TD, Sempf JM, Oberley LW. Immunolocalization of antioxidant enzymes in adult hamster kidney. Histochem J 1994; 26: 734-753
15. 2 in biomembranes. Biochim Biophys Acta 1982; 694: 69-93
16. Taniguchi N. Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer. Adv Clin Chem 1992; 29: 1-59
17. Malle E, Woenckhaus C, Waeg G, Esterbauer H, Grone EF, Grone HJ. Immunological evidence for hypochlorite-modified proteins in human kidney. Am J Pathol 1997; 150: 603-615
18. Ichikawa I, Kiyama S, Yoshioka T. Renal antioxidant enzymes: their regulation and function [editorial]. Kidney Int 1994; 45: 1-9
19. Janssen YM, Van Houten B, Borm PJ, Mossman BT. Cell and tissue responses to oxidative damage. Lab Invest 1993; 69: 261-274
20. Gwinner W, Deters-Evers U, Brandes RP et al. Antioxidant-oxidant balance in the glomerulus and proximal tubule of the rat kidney. J Physiol (Lond) 1998; 509: 599-606
21. Deby C, Goutier R. New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases. Biochem Pharmacol 1990; 39: 399-405
22. Niki E, Noguchi N, Gotoh N. Dynamics of lipid peroxidation and its inhibition by antioxidants. Biochem Soc Trans 1993; 21: 313-317
23. Bray RC, Cockle SA, Fielden EM, Roberts PB, Rotilio G, Calabrese L. Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochem J 1974; 139: 43-48
24. Fligiel SE, Lee EC, McCoy JP, Johnson KJ, Varani J. Protein degradation following treatment with hydrogen peroxide. Am J Pathol 1984; 115: 418-425
25. Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science 1988; 240: 1302-1309
26. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 1997; 11: 118-124
27. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709-720
28. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997; 22: 269-285
29. Gwinner W, Landmesser U, Brandes RP et al. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J Am Soc Nephrol 1997; 8: 1722-1731
30. Kawaguchi M, Yamada M, Wada H, Okigaki T. Roles of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicology 1992; 72: 329-340
31. Nakamura K, Kojima K, Arai T et al. Dipyridamole and dilazep suppress oxygen radicals in puromycin aminonucleoside nephrosis rats. Eur J Clin Invest 1998; 28: 877-883
32. Ricardo SD, Bertram JF, Ryan GB. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Exp Nephrol 1995; 3: 270-279
33. Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int 1991; 40: 291-301
34. Wang JS, Yang AH, Chen SM, Young TK, Chiang H, Liu HC. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis. Nephron 1993; 65: 418-425
35. Ginevri F, Gusmano R, Oleggini R et al. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis. Clin Sci 1990; 78: 283-293
36. Bertolatus JA, Klinzman D, Bronsema DA, Ridnour L, Oberley LW. Evaluation of the role of reactive oxygen species in doxorubicin hydrochloride nephrosis. J Lab Clin Med 1991; 118: 435-445
37. Gustafson DL, Swanson JD, Pritsos CA. Modulation of glutathione and glutathione dependent antioxidant enzymes in mouse heart following doxorubicin therapy. Free Radic Res Commun 1993; 19: 111-120
38. Julicher RH, Sterrenberg L, Haenen GR, Bast A, Noordhoek J. The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat. Arch Toxicol 1988; 61: 275-281
39. Montilla P, Tunez I, Munoz MC, Lopez A, Soria JV. Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration. Nephron 1997; 76: 345-350
40. Ohtake T, Kimura M, Nishimura M, Hishida A. Roles of reactive oxygen species and antioxidant enzymes in murine daunomycin-induced nephropathy. J Lab Clin Med 1997; 129: 81-88
41. Gaertner S, Floege J, Janssen U et al. Glomerular oxidative and antioxidative activity in experimental mesangioproliferative glomerulonephritis (abstract). J Am Soc Nephrol 1997; 8: 472A-473A
42. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW. Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int 1990; 37: 1500-1508
43. Scheuer H, Gwinner W, Hohbach J et al. Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol 2000; 278: F63-F74
44. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 1993; 90: 3645-3649
45. Gwinner W, Plasger J, Brandes RP et al. Role of xanthine oxidase in passive Heymann nephritis in rats. J Am Soc Nephrol 1999; 10: 538-544
46. Hattori T, Ito M, Suzuki Y. Changes in intra-renal scavenging enzymes activities of the reactive oxygen species in experimental glomerulonephritis and nephrosis in rats. Nippon Jinzo Gakkai Shi 1991; 33: 191-199
47. Boyce NW, Tipping PG, Holdsworth SR. Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int 1989; 35: 778-782
48. Yoshioka T, Homma T, Meyrick B et al. Oxidants induce transcriptional activation of manganese superoxide dismutase in glomerular cells. Kidney Int 1994; 46: 405-413
49. Macconi D, Zanoli AF, Orisio S et al. Methylprednisolone normalizes superoxide anion production by polymorphs from patients with ANCA-positive vasculitides. Kidney Int 1993; 44: 215-220
50. Wang JS, Ger LP, Tseng HH. Expression of glomerular antioxidant enzymes in human glomerulonephritis. Nephron 1997; 76: 32-38
51. Arao F, Yamada H, Katsumi K. Cu, Zn-superoxide dismutase, glutathione peroxidase location in kidney of IgA nephropathy. Nippon Jinzo Gakkai Shi 1992; 34: 1047-1053
52. Chen HC, Tomino Y, Yaguchi Y, Fukui M, Koide H. Detection of polymorphonuclear cells, superoxide dismutase and poly C9 in glomeruli of patients with IgA nephropathy [letter]. Nephron 1991; 59: 338
53. Futenma A, Yamada H, Kato K, Taki K. Distribution of glutathione peroxidase in the glomeruli of IgA nephropathy. Rinsho Byori 1994; 42: 1177-1181
54. Phillis JW, Sen S, Cao X. Amflutizole, a xanthine oxidase inhibitor, inhibits free radical generation in the ischemic/reperfused rat cerebral cortex. Neurosci Lett 1994; 169: 188-190
55. Chatham WW, Baggott JE, Loose LD, Blackburn WD Jr. Effects of tenidap on superoxide-generating enzymes. Noncompetitive inhibition of xanthine oxidase. Biochem Pharmacol 1995; 50: 811-814
56. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148
57. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996; 271: 23317-23321
58. Mahomed AG, Theron AJ, Anderson R, Feldman C. Antioxidative effects of theophylline on human neutrophils involve cyclic nucleotides and protein kinase A. Inflammation 1998; 22: 545-557
59. Chini CC, Chini EN, Williams JM, Matousovic K, Dousa TP. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Kidney Int 1994; 46: 28-36
60. Land W, Zweler JL. Prevention of reperfusion-induced, free radical-mediated acute endothelial injury by superoxide dismutase as an effective tool to delay/prevent chronic renal allograft failure: a review. Transplant Proc 1997: 29: 2567-2568
61. Faulkner KM, Liochev SI, Fridovich I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J Biol Chem 1994; 269: 23471-23476
62. Narayanaswami V, Sies H. Oxidative damage to mitochondria and protection by ebselen and other antioxidants. Biochem Pharmacol 1990; 40: 1623-1629
63. Salvemini D, Wang ZQ, Zweier JL et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999; 286: 304-306
64. Frank J, Biesalski HK. Involvement of reactive oxygen species in the progression of renal disease and the significance of antioxidants in therapy. Nieren-Hochdruckkrankh 1997; 26: 342-347
65. Tahzib M. Frank R, Gauthier B, Valderrama E, Trachtman H. Vitamin E treatment of focal segmental glomerulosclerosis: results of an open-label study. Pediatr Nephrol 1999; 13: 649-652
66. Scheinman JI, Trachtman H, Lin CY, Langman CB, Chan JC. IgA nephropathy: to treat or not to treat? Nephron 1997; 75: 251-258
67. Haas M, Kerjaschki D, Mayer G. Lipid-lowering therapy in membranous nephropathy. Kidney Int 1999; 71 [Suppl.]: S110-112
68. Andreoli SP. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury. Am J Physiol 1993; 264: F120-F127
69. Moser M, Frishman W. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients. Am J Hypertens 1998; 11: 15S-22S
70. Kang MY, Tsuchiya M, Packer L, Manabe M. In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand 1998; 42: 4-12
71. Gwinner W, Tisher CC, Nick HS. Regulation of manganese superoxide dismutase in glomerular epithelial cells: mechanisms for interleukin 1 induction. Kidney Int 1995; 48: 354-362
72. Stephanz GB, Gwinner W, Cannon JK, Tisher CC, Nick HS. Heat-aggregated IgG and interleukin-1 beta stimulate manganese superoxide dismutase in mesangial cells. Exp Nephrol 1996; 4: 151-158
73. de Cavanagh EM, Fraga CG, Ferder L, Inserra F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol 1997; 272: R514-R518
74. Shou I, Wang LN, Suzuki S, Fukui M, Tomino Y. Effects of antihypertensive drugs on antioxidant enzyme activities and renal function in stroke-prone spontaneously hypertensive rats. Am J Med Sci 1997; 314: 377-384
75. Verbeelen DL, De Craemer D, Peeters P, Vanden Houte K, Van den Branden C. Enalapril increases antioxidant enzyme activity in renal cortical tissue of five-sixths-nephrectomized rats. Nephron 1998; 80: 214-219
76. Pfeffer KD, Huecksteadt TP, Hoidal JR. Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation. J Immunol 1994; 153: 1789-1797
77. Paller MS, Eaton JW. Hazards of antioxidant combinations containing superoxide dismutase. Free Radic Biol Med 1995; 18: 883-890